Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
ATL001 + Pembrolizumab for Lung Cancer
Recruiting2 awardsPhase 1 & 2
Tampa, Florida
This trial will study the safety and activity of a new treatment for advanced non-small cell lung cancer. The treatment involves taking T cells from the patient, modifying them to recognize and attack cancer cells, and then giving them back to the patient intravenously.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.